VEGF and Hypoxia Independently Induce MDR1 Expression to Promote Endothelial Cell Angiogenesis

View at publisher Summarise with VIRAT
Authors: Hyeong Sim Choi, Sung‐Gook Cho, Min Kyoung Kim, Seong‐Gyu Ko, Pil‐Young Yun
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background/Aim: Angiogenesis is a critical process in endothelial biology and tumor progression, primarily regulated by vascular endothelial growth factor (VEGF) and hypoxia. Multidrug resistance protein 1 (MDR1), best known for its role in drug efflux, has recently been implicated in endothelial function. This study aimed to investigate whether VEGF and hypoxia independently regulate MDR1 expression in human umbilical vein endothelial cells (HUVECs) and to elucidate the functional role of MDR1 in angiogenesis. Materials and Methods: HUVECs were treated with VEGF or exposed to hypoxic conditions (1% O2 or CoCl2). MDR1 mRNA expression was assessed by quantitative real-time PCR, whereas MDR1 protein expression was evaluated by Western blotting, flow cytometry, and immunofluorescence. Functional assays, including migration, invasion, tube formation, and cell viability, were performed following MDR1 overexpression or siRNA-mediated knockdown. HIF-1α overexpression was used to examine hypoxia-mediated regulation. Results: VEGF induced MDR1 expression in a dose- and time-dependent manner. VEGF-induced MDR1 expression was predominantly localized intracellularly and did not significantly enhance drug efflux activity. MDR1 overexpression promoted endothelial migration, invasion, tube formation, and cell viability even in the absence of VEGF, whereas MDR1 knockdown attenuated VEGF-induced angiogenic responses. Hypoxia and hypoxia-inducible factor 1-alpha (HIF-1α) overexpression also significantly upregulated MDR1 expression independently of VEGF. Conclusion: VEGF and hypoxia independently induce MDR1 expression in endothelial cells through distinct signaling pathways. MDR1 functions as a key mediator of angiogenesis independent of its classical drug efflux role, highlighting its potential as a therapeutic target in angiogenesis-related vascular diseases.

Fields of Study & Subjects

Angiogenesis and VEGF in Cancer Drug Transport and Resistance Mechanisms Lymphatic System and Diseases

Publication details

Journal / source
Anticancer Research
Volume
46
Issue
4
Pages
1903–1916
Publication date
27 March 2026
Language
EN